• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Issues in the cross-national assessment of health technology.

作者信息

Drummond M F, Bloom B S, Carrin G, Hillman A L, Hutchings H C, Knill-Jones R P, de Pouvourville G, Torfs K

机构信息

University of York.

出版信息

Int J Technol Assess Health Care. 1992 Fall;8(4):671-82. doi: 10.1017/s0266462300002361.

DOI:10.1017/s0266462300002361
PMID:1464487
Abstract

With the growing international literature in economic evaluation and the rapid spread of new health technologies, there is a need to undertake, or at least interpret, economic evaluations on the international level. However, the ways in which cross-national differences affect the cost-effectiveness of health technologies or their evaluations have never been studied. This paper explores these issues by taking advantage of a unique situation in which the same economic evaluation of a new indication for a health technology was conducted simultaneously in four countries using an identical methodology. The study showed that if prior agreement on methods can be reached and local data applied, economic evaluations can be undertaken in a way that facilitates the extrapolation of results from country to country.

摘要

相似文献

1
Issues in the cross-national assessment of health technology.
Int J Technol Assess Health Care. 1992 Fall;8(4):671-82. doi: 10.1017/s0266462300002361.
2
The preliminary economic evaluation of health technologies for the prioritization of health technology assessments. A discussion.
Int J Technol Assess Health Care. 1998 Fall;14(4):652-62. doi: 10.1017/s026646230001196x.
3
Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies.提高经济评估的可推广性:关于研究设计、分析和报告的建议。
Int J Technol Assess Health Care. 2005 Spring;21(2):165-71.
4
Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.卫生技术评估:卫生政策中的经济问题与经济评估中的政策问题。
Soc Sci Med. 1994 Jun;38(12):1593-600. doi: 10.1016/0277-9536(94)90059-0.
5
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study.比较不同组织提交给英国国家卫生与临床优化研究所(NICE)的成本效益评估:回顾性研究。
BMJ. 2005 Jan 8;330(7482):65. doi: 10.1136/bmj.38285.482350.82. Epub 2004 Dec 15.
6
Cost-effectiveness and misoprostol.成本效益与米索前列醇
Arch Intern Med. 1995 Jul 10;155(13):1448, 1451-2. doi: 10.1001/archinte.155.13.1448b.
7
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.欧洲对卫生经济评估有统一观点吗?欧盟网络卫生技术评估合作国所用方法指南概要的结果
Pharmacoeconomics. 2016 Jan;34(1):59-76. doi: 10.1007/s40273-015-0328-1.
8
Health technology assessment and economic evaluation: arguments for a national approach.卫生技术评估与经济评估:支持采用国家方法的论据。
Value Health. 2010 Sep-Oct;13(6):859-61. doi: 10.1111/j.1524-4733.2010.00765.x. Epub 2010 Aug 4.
9
Has the cost-effectiveness of misoprostol been underestimated?
Arch Intern Med. 1995 Jul 10;155(13):1448, 1451-2. doi: 10.1001/archinte.155.13.1448a.
10
Evaluating evaluations of new health technologies.评估新卫生技术的评估
Pharmacoeconomics. 1993 Jun;3(6):511-2. doi: 10.2165/00019053-199303060-00009.

引用本文的文献

1
Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States.短程放疗联合替莫唑胺治疗中美老年新诊断胶质母细胞瘤的成本效益分析
Front Pharmacol. 2021 Sep 27;12:743979. doi: 10.3389/fphar.2021.743979. eCollection 2021.
2
The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.泰国儿童急性腹泻使用辅助消旋卡多曲的成本效用及预算影响
Clinicoecon Outcomes Res. 2017 Jul 17;9:411-422. doi: 10.2147/CEOR.S140902. eCollection 2017.
3
An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
泰国应用串联质谱法对先天性代谢缺陷进行新生儿筛查的经济学评估。
PLoS One. 2015 Aug 10;10(8):e0134782. doi: 10.1371/journal.pone.0134782. eCollection 2015.
4
Evaluating the Generalisability of Trial Results: Introducing a Centre- and Trial-Level Generalisability Index.评估试验结果的可推广性:引入中心和试验层面的可推广性指数。
Pharmacoeconomics. 2015 Nov;33(11):1195-214. doi: 10.1007/s40273-015-0298-3.
5
Clinical management and burden of prostate cancer: a Markov Monte Carlo model.前列腺癌的临床管理与负担:马尔可夫蒙特卡罗模型
PLoS One. 2014 Dec 4;9(12):e113432. doi: 10.1371/journal.pone.0113432. eCollection 2014.
6
Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool.肿瘤学中医疗成本评估在不同地点间的可转移性:聚类分析和主成分分析作为一种探索工具
BMC Health Serv Res. 2014 Nov 18;14:537. doi: 10.1186/s12913-014-0537-x.
7
Potential transferability of economic evaluations of programs encouraging physical activity in children and adolescents across different countries--a systematic review of the literature.鼓励儿童和青少年进行体育活动项目的经济评估在不同国家间的潜在可转移性——文献系统综述
Int J Environ Res Public Health. 2014 Oct 15;11(10):10606-21. doi: 10.3390/ijerph111010606.
8
The road not taken: transferability issues in multinational trials.未走之路:跨国试验中的可转移性问题。
Pharmacoeconomics. 2013 Oct;31(10):863-76. doi: 10.1007/s40273-013-0084-z.
9
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United States.替莫唑胺在新诊断的胶质母细胞瘤辅助治疗中的成本效益:美国的研究
Neuro Oncol. 2013 Nov;15(11):1532-42. doi: 10.1093/neuonc/not096. Epub 2013 Aug 9.
10
Centre selection for clinical trials and the generalisability of results: a mixed methods study.中心选择对临床试验和结果的普遍性的影响:一项混合方法研究。
PLoS One. 2013;8(2):e56560. doi: 10.1371/journal.pone.0056560. Epub 2013 Feb 22.